These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 18023510)

  • 21. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
    Field EJ; Vally H; Grimwood K; Lambert SB
    Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.
    Curns AT; Coffin F; Glasser JW; Glass RI; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S49-56. PubMed ID: 19817614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico.
    Yen C; Figueroa JR; Uribe ES; Carmen-Hernández LD; Tate JE; Parashar UD; Patel MM; Richardson López-Collado V
    J Infect Dis; 2011 Sep; 204(5):783-6. PubMed ID: 21810915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
    Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
    J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.
    Desai SN; Esposito DB; Shapiro ED; Dennehy PH; Vázquez M
    Vaccine; 2010 Nov; 28(47):7501-6. PubMed ID: 20851087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus gastroenteritis in uzbekistan: implications for vaccine policy in central Asia.
    Flem ET; Musabaev E; Juraev R; Kerin T; Gentsch J; Glass RI; Bresee JS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S154-9. PubMed ID: 19817594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study results show potential impact of rotavirus vaccine on hospitalization rates of children.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1115. PubMed ID: 21854305
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.
    Gosselin V; Généreux M; Gagneur A; Petit G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2572-2579. PubMed ID: 27367155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.
    Cortese MM; Tate JE; Simonsen L; Edelman L; Parashar UD
    Pediatr Infect Dis J; 2010 Jun; 29(6):489-94. PubMed ID: 20354464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
    Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
    Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.